arrow_back Back to App

US House: Keep COVID Vaccine Patent Rights

The US House of Representatives believes the United States should keep intellectual property rights for COVID-19 vaccines and treatments. They argue that patent protection is important for developing new medicines and is not the main reason for vaccine shortages, which are due to logistics and manufacturing.
Key points
The US should protect patents for COVID-19 vaccines, treatments, and related technologies.
Waiving patents would harm the development of new medicines, weaken US businesses, and damage future pandemic response capabilities.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HRES_484
Sponsor: Rep. Miller-Meeks, Mariannette [R-IA-2]
Process start date: 2021-06-17
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-04-17
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HRES_484.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-06-17.

What are the main provisions?

Key points include:

  • The US should protect patents for COVID-19 vaccines, treatments, and related technologies.
  • Waiving patents would harm the development of new medicines, weaken US businesses, and damage future pandemic response capabilities.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Miller-Meeks, Mariannette [R-IA-2].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health Economy